Life Science Leader Magazine Supplements

CRO Leadership Awards 2013

The vision of Life Science Leader is to be an essential business tool for life science executives. Our content is designed to not only inform readers of best practices, but motivate them to implement those best practices in their own businesses.

Issue link: https://lifescienceleadermag.epubxp.com/i/111709

Contents of this Issue

Navigation

Page 11 of 45

Contract Research Organizations Mary Rose Keller, Sangart: Commodification of clinical research is not attractive to R&D; colleagues. It suggests that success lies in faster and cheaper, not in better outcomes for patients or investors. Bid defense should be more about how the CRO approach will deliver quality data to define a clear outcome than reviewing hundreds of lines of cost detail. Metrics are important, but how they are achieved is more important. Keep the messages simple. If you can draw your study management organization on the back of a napkin in the lobby of the hotel, you can probably run my study. DESCRIBE A SITUATION WHEN YOU WISH YOU HAD OUTSOURCED SOONER AND WHY? Green: I can share a time when I wish we had switched vendors sooner. We were working with a small non-GMP protein manufacturer to take a university manufacturing process from the first small-scale validation of the process through to making the first material. As the lots grew slightly larger, the material was tending to be more insoluble, and therefore, would require the expertise of a team with experience in removing proteins from inclusion bodies. The vendor didn���t have that expertise. A mistake can occur when work shifts and the focus moves outside the vendor���s level of expertise. of the work could have been performed at the same time, thus resulting in the earlier (and potentially less stressful) completion of the entire project. Keller: In a previous company, we needed to conduct a very simple classical Phase 3 study in a common condition. At the same time, we were going to start a new program with the same Mitch Katz, Purdue Pharma L.P.: While implementing certain development plans, I have needed to work sequentially. If I had utilized outsourcing, much In the big world of clinical trials, it���s the small stuff that counts. &�������������������������������������������������������� ������������������������������������������������������������������������������������ >����WZ������������������������������������������������������������������������������������������ clearlypra.com >���������������� ���������������� ���������������� ���������������� W��������/ /s &������ ^�������������������������������������������������������������������� d������������������������������������d������������������������ K����W���������� /���������������� - Transparency ��WZ�������� ����Z����������Z�������������� �� ����

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CRO Leadership Awards 2013